BUY Balrampur Chini Mills Limited — IDBI Capital
byIDBI CapitalHorizon: NA (inferred Swing (≤2wk))4 Nov 2026via IDBI Capital Research Calls Telegram
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Past week's volume 1.9× the 30-day average
Technicals · volume·6 Nov · yesterday
Balrampur Chini Mills reported Q2 FY27 consolidated revenue of Rs 1,876.28 crore (up 12.3% YoY) and EBITDA of Rs 171.40 crore (up 42.4% YoY). The company also declared an interim dividend of Rs 4 per
BSE · Company Update·4 Nov · 2d ago
Balrampur Chini Mills reported Q2 FY27 financial results with a 12.3% increase in revenue and a 42.4% increase in EBITDA compared to Q2 FY26. The company also declared an interim dividend of Rs 4.00 p
NSE · Press Release·4 Nov · 2d ago
Balrampur Chini Q2 Results: Shareholders To Get Rs 4 Dividend After 90% Profit Jump; Check Key Numbers
NewsNdtv-Profit·4 Nov · 3d ago
The company reported standalone and consolidated financial results for the quarter and half-year ended September 30, 2026, and declared an interim dividend of 400% (Rs 4 per share).
BSE · Board Meeting·4 Nov · 3d ago
Nothing found in this tip’s window yet.
MACD below its signal line — bearish momentum
Technicals · macd·7 Nov · today
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Balrampur Chini Mills
- BUY — Elara Capital6 Nov 2026 · ~1 year · target ₹874 · Active
- BUY — Somil Mehta, Sharekhan16 Oct 2026 · ~3 months · target ₹800 · SL hit
- BUY — IDBI Capital13 Oct 2026 · ~3 months · target ₹778 · SL hit
- BUY — Amol Athawale, Kotak Securities13 Oct 2026 · ~3 months · target ₹740 · SL hit
- BUY — Rajesh Satpute12 Oct 2026 · ~2 weeks · target ₹740 · SL hit
More from IDBI Capital
- BUY Alkem Laboratories6 Nov 2026 · ~2 weeks · target ₹5,460 · Active
- BUY Onesource Specialty Pharma6 Nov 2026 · ~2 weeks · target ₹1,735 · Active
- BUY Sun Pharmaceutical Industries6 Nov 2026 · ~2 weeks · target ₹1,925 · Active
- BUY Vijaya Diagnostic Centre6 Nov 2026 · ~2 weeks · target ₹1,575 · Active
- BUY Rolex Rings6 Nov 2026 · ~1 year · target ₹241 · Active

